Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
- 31 December 1994
- journal article
- Published by Elsevier BV in Immunity
- Vol. 1 (9), 751-761
- https://doi.org/10.1016/s1074-7613(94)80017-0
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA‐DRw17(DR3) moleculesEuropean Journal of Immunology, 1992
- Identification of self peptides bound to purified HLA-B27Nature, 1991
- The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformationNature, 1991
- Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolutionJournal of Molecular Biology, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb moleculeNature, 1990
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b diseaseThe Journal of Pediatrics, 1988